Journal for ImmunoTherapy of Cancer (Nov 2020)
102 Cord-blood derived NK cells, and CAR-T cells, an attractive improved immunotherapy treatment to be considered for hematological malignancies
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2020)